Skip to main content

Table 2 Subjects’ characteristics before and after the n-3 PUFA supplementation (n = 208; Men = 96 (46%) and Women = 112 (54%))

From: Gene-diet interactions with polymorphisms of the MGLL gene on plasma low-density lipoprotein cholesterol and size following an omega-3 polyunsaturated fatty acid supplementation: a clinical trial

  Pre1 Post1 p2
Age (years) 30.8 ± 8.7  
Weight (kg)4 81.0 ± 13.7 81.2 ± 14.0 0.8
BMI (kg/m2)3,4 27.6 ± 3.4 27.7 ± 3.6 0.8
Waist circumference (cm)4 93.0 ± 10.0 93.0 ± 10.1 0.9
Total cholesterol (mmol/L)5 4.72 ± 0.88 4.69 ± 0.91 0.6
HDL (mmol/L)5 1.43 ± 0.35 1.46 ± 0.39 0.3
LDL (mmol/L)5 2.75 ± 0.82 2.77 ± 0.85 0.9
Triglycerides (mmol/L)3,5 1.19 ± 0.62 1.01 ± 0.51 0.0001*
Apolipoprotein B (g/L)5 0.83 ± 0.24 0.86 ± 0.23 0.2
LDL size (Å)5 254.06 ± 2.65 254.21 ± 2.79 0.6
  1. *p < 0.05 1Values are means ± SD, 2ANOVA for the differences before and after the supplementation, 3Values are log(10) transformed, 4Results adjusted for age and sex, 5Results adjusted for age, sex and BMI.